231 related articles for article (PubMed ID: 19126950)
1. Coil embolization of septal artery as a treatment for hypertrophic obstructive cardiomyopathy.
Bahl A
Indian Heart J; 2007; 59(4):382. PubMed ID: 19126950
[No Abstract] [Full Text] [Related]
2. Percutaneous transluminal catheter-based coil embolization of septal artery as a treatment for hypetrophic obstructive cardiomyopathy.
Vaishnav S; Gautam N
Indian Heart J; 2007; 59(2):195-6. PubMed ID: 19122258
[No Abstract] [Full Text] [Related]
3. Delayed response following trans-catheter coil embolization in HOCM.
Math RS; Singh S; Seth S; Shankar B; Bhargava B; Sharma S; Gulati G
Indian Heart J; 2007; 59(4):383-5. PubMed ID: 19126951
[No Abstract] [Full Text] [Related]
4. Coil embolization of septal artery as a treatment for hypertrophic obstructive cardiomyopathy.
Bahl A
Indian Heart J; 2008; 60(3):273. PubMed ID: 19240323
[No Abstract] [Full Text] [Related]
5. Non-surgical myocardial ablation: for hypertrophic obstructive cardiomyopathy.
Sigwart U
Cardiologia; 1998 Feb; 43(2):157-61. PubMed ID: 9557371
[No Abstract] [Full Text] [Related]
6. Effectiveness of percutaneous intervention for patients with obstructive hypertrophic cardiomyopathy and coronary artery disease.
Nambi V; Buergler JM; Lakkis NM; Franklin J; Spencer WH; Nagueh SF
Am J Cardiol; 2005 Aug; 96(4):580-1. PubMed ID: 16098315
[TBL] [Abstract][Full Text] [Related]
7. Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy: early and 6 months follow-up.
Durand E; Mousseaux E; Coste P; Pillière R; Dubourg O; Trinquart L; Chatellier G; Hagège A; Desnos M; Lafont A
Eur Heart J; 2008 Feb; 29(3):348-55. PubMed ID: 18203702
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous transluminal septal coil embolisation as an alternative to alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
Lafont A; Durand E; Brasselet C; Mousseaux E; Hagege A; Desnos M
Heart; 2005 Jan; 91(1):92. PubMed ID: 15604345
[No Abstract] [Full Text] [Related]
9. Pericardium-covered stent for septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
Gaspar J; Martínez-Ríos MA; Vonderwalde C; Rosas M; Ban-Hayashi E; Eidt-Lidt G; Kuri J
Catheter Cardiovasc Interv; 1999 May; 47(1):73-9. PubMed ID: 10385166
[TBL] [Abstract][Full Text] [Related]
10. [The induction of a septal infarct as a therapeutic alternative in hypertrophic obstructive cardiomyopathy: new observations apropos a case].
de la Torre Hernández JM; Sánchez Mata N; Riesco Riesco F; Ruiz Delgado B; Ochoteco Azcárate A; Zueco Gil J; Colman Dejean T
Rev Esp Cardiol; 1999 May; 52(5):339-42. PubMed ID: 10368585
[TBL] [Abstract][Full Text] [Related]
11. Successful coronary stenting of the left anterior descending artery at the branching site of the targeted septal perforator immediately after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
Honda T; Sakamoto T; Miyamoto S; Sugiyama S; Yoshimura M; Ogawa H
Intern Med; 2005 Jul; 44(7):722-6. PubMed ID: 16093594
[TBL] [Abstract][Full Text] [Related]
12. Regional dyssynergy of the interventricular septum after septal artery occlusion in hypertrophic obstructive cardiomyopathy: use of quantitative Doppler tissue and strain rate imaging.
Sengupta PP; Trehan VK; Mehta V; Arora R; Khandheria BK
J Am Soc Echocardiogr; 2004 Apr; 17(4):384-6. PubMed ID: 15044874
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous transluminal septal myocardial ablation: a new treatment for hypertrophic obstructive cardiomyopathy.
Seggewiss H
Eur Heart J; 2000 May; 21(9):704-7. PubMed ID: 10739723
[No Abstract] [Full Text] [Related]
14. Percutaneous transseptal myocardial ablation with wire (PTSAW): a new technique.
Trehan V; Mukhopadhyay S; Rangasetty UC
J Invasive Cardiol; 2004 Apr; 16(4):204-6. PubMed ID: 15152148
[TBL] [Abstract][Full Text] [Related]
15. Acute hemodynamic changes in percutaneous transluminal septal coil embolization for hypertrophic obstructive cardiomyopathy.
Ramcharitar S; Meliga E; Kirschbaum SW; ten Cate FJ; van Geuns RJ; Serruys PW
Nat Clin Pract Cardiovasc Med; 2008 Dec; 5(12):806-10. PubMed ID: 18838967
[TBL] [Abstract][Full Text] [Related]
16. Cardiac electromechanical mapping in analyzing the mechanism of left ventricular remodeling immediately after percutaneous transluminal septal ablation in patients with hypertrophic obstructive cardiomyopathy.
Chen SL; Huang J; Ye F; Shan SJ; Zhang JJ; Duan BX; Chen YD
Chin Med J (Engl); 2005 Nov; 118(21):1779-85. PubMed ID: 16336814
[TBL] [Abstract][Full Text] [Related]
17. Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy in South Carolina: the MUSC experience (1999 through 2001).
Nielsen CD; Killip D; Spencer WH
J S C Med Assoc; 2002 Apr; 98(2):62-5. PubMed ID: 11975139
[No Abstract] [Full Text] [Related]
18. Acute decompensation of hypertrophic obstructive cardiomyopathy secondary to A-V disassociation: successful treatment with a combination of alcohol septal ablation and permanent pacemaker.
Rohatgi S; Wiegers SE; Hsia H; Herling I; Herrmann HC
J Interv Cardiol; 2005 Oct; 18(5):401-6. PubMed ID: 16202120
[TBL] [Abstract][Full Text] [Related]
19. Transcatheter ablation of septal hypertrophy: a promising alternative to surgery in hypertrophic obstructive cardiomyopathy.
Keren A; Banai S
Isr Med Assoc J; 2002 Feb; 4(2):114-6. PubMed ID: 11875983
[No Abstract] [Full Text] [Related]
20. Left ventricular outflow tract obstruction in the presence of asymmetric septal hypertrophy and accessory mitral valve tissue treated with alcohol septal ablation.
Kim MS; Klein AJ; Groves BM; Quaife RA; Salcedo EE
Eur J Echocardiogr; 2008 Sep; 9(5):720-4. PubMed ID: 18490281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
